Vitamin D Supplementation and Colorectal Cancer Patients Outcomes

Noeray Pratiwi Mulyadi, Reno Rudiman, Andriana Purnama

Abstract


Colorectal cancer is the third most encountered malignancy worldwide in 2018. Some earlier studies indicate a significant influence of vitamin D supplementation on the 5-year survival rate and the rate of metastasis progression in colorectal cancer patients. Studies investigating the effects of vitamin D supplementation on the outcomes of colorectal cancer patients are limited in Indonesia. Therefore, a double-blinded Randomized Controlled Trial (RCT) of the effect of vitamin D supplementation on the outcome of colorectal cancer patients was conducted from April 2022 to March 2023 at the digestive surgery outpatient clinic of Dr. Hasan Sadikin General Hospital Bandung, Indonesia. In this study, 36 patients received vitamin D and 34 patients received a placebo. Data analysis performed using the multivariate analysis with multiple regression revealed no significant relationship between vitamin D supplementation and colorectal cancer patient outcomes. Furthermore, ANOVA analysis indicated no relationship between the analyzed independent and dependent variables in this study.  No relationship was found between vitamin D supplementation and the outcomes of metastasis, mortality, and Karnofsky scores in colorectal cancer patients. Further research with a larger population is still needed to determine the benefits of vitamin D supplementation on the outcomes of colorectal cancer patients.


Keywords


Colorectal neoplasms, neoplasm metastasis, mortality, vitamin D, supplementation

Full Text:

PDF

References


  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660
  2. The American Cancer Society. Colorectal Cancer Statistics | How Common Is Colorectal Cancer? | American Cancer Society. [Internet] 2024. [cited 2024 January 25]. Available from: https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html
  3. Javed M, Althwanay A, Ahsan F, Oliveri F, Goud HK, Mehkari Z, et al. Role of Vitamin D in Colorectal Cancer: A Holistic Approach and Review of the Clinical Utility. Cureus. 2020;12(9):e10734. doi:10.7759/cureus.10734
  4. Yamagishi H, Kuroda H, Imai Y, Hiraishi H. Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer. 2016;35(1):4. doi:10.1186/s40880-015-0066-y
  5. Guraya S. Chemopreventive role of vitamin D in colorectal carcinoma. J Microsc Ultrastruct. 2014;2(1):1. doi:10.1016/j.jmau.2013.09.001
  6. Aggarwal A, Höbaus J, Tennakoon S, Prinz-Wohlgenannt M, Graça J, Price SA, et al. Active vitamin D potentiates the anti-neoplastic effects of calcium in the colon: A cross talk through the calcium-sensing receptor. J Steroid Biochem Mol Biol. 2016;155:231–8. doi:10.1016/j.jsbmb.2015.02.006
  7. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720–55. doi:10.1016/j.mayocp.2013.05.011
  8. Antunac Golubić Z, Baršić I, Librenjak N, Pleština S. Vitamin D supplementation and survival in metastatic colorectal cancer. Nutr Cancer. 2018;70(3):413–7. doi:10.1080/01635581.2018.1445766
  9. Isbilen E, Kus T, Yesil Cinkir H, Aktas G, Buyukbebeci A. Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors. Turkish J Biochemistry. 2021;46(5):509–16. doi:10.1515/tjb-2021-0137
  10. Yuan C, Ng K. Vitamin D supplementation: a potential therapeutic agent for metastatic colorectal cancer. Br J Cancer. 2020;123(8):1205–6. doi:10.1038/s41416-020-0958-8
  11. Morelli C, Rofei M, Riondino S, Fraboni D, Torino F, Orlandi A, et al. Immune response in vitamin D deficient metastatic colorectal cancer patients: a player that should be considered for targeted vitamin D Supplementation. Cancers (Basel). 2022;14(11):2594. doi:10.3390/cancers14112594
  12. Urashima M, Ohdaira H, Akutsu T, Okada S, Yoshida M, Kitajima M, et al. Effect of vitamin D supplementation on relapse-free survival among patients with digestive tract cancers. JAMA. 2019;321(14):1361. doi:10.1001/jama.2019.2210
  13. Vaughan-Shaw PG, O'Sullivan F, Farrington SM, Theodoratou E, Campbell H, Dunlop MG, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer. 2017;116(8):1092–10. doi:10.1038/bjc.2017.44
  14. Song M, Lee IM, Manson JE, Buring JE, Dushkes R, Gordon D, et al. No association between vitamin D supplementation and risk of colorectal adenomas or serrated polyps in a randomized trial. Clinical Gastroenterology and Hepatology. 2021;19(1):128–35.e6. doi:10.1016/j.cgh.2020.02.013
  15. Mezawa H, Sugiura T, Watanabe M, Norizoe C, Takahashi D, Shimojima A, et al. Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study. BMC Cancer. 2010;10(1):347. doi:10.1186/1471-2407-10-347
  16. McCullough ML, Zoltick ES, Weinstein SJ, et al. Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. JNCI: Journal of the National Cancer Institute. 2019;111(2):158–69. doi:10.1093/jnci/djy087
  17. Milczarek M, Psurski M, Kutner A, Wietrzyk J. Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivomouse colon cancer model. BMC Cancer. 2013;13(1):294. doi:10.1186/1471-2407-13-294
  18. Ng K, Nimeiri HS, McCleary NJ, et al. Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer. JAMA. 2019;321(14):1370. doi:10.1001/jama.2019.2402
  19. Klampfer L. Vitamin D and colon cancer. World J Gastrointest Oncol. 2014;6(11):430. doi:10.4251/wjgo.v6.i11.430
  20. Refaat B, El-Shemi AG, Kensara OA, et al. Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer.J Exp Clin Cancer Res. 2015;34(1):71. doi:10.1186/s13046-015-0187-9




DOI: https://doi.org/10.15395/mkb.v56.3823

Article Metrics

Abstract view : 157 times
PDF - 64 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats